Design of liposomes as drug delivery system for therapeutic applications

被引:687
作者
Guimaraes, Diana [1 ]
Cavaco-Paulo, Artur [1 ,2 ]
Nogueira, Eugenia [1 ,2 ]
机构
[1] Univ Minho, Ctr Biol Engn, Braga, Portugal
[2] Solfarcos Pharmaceut & Cosmet Solut, Braga, Portugal
基金
欧盟地平线“2020”;
关键词
Liposomes; Drug delivery; Liposome production; Liposome characterization; Market liposomes; NANOPARTICLE TRACKING ANALYSIS; ENCAPSULATION EFFICIENCY; CANCER-THERAPY; PHOSPHOLIPIDS; GENERATION; FLUORESCENT; EXPERIENCE; CHALLENGES; STRATEGIES; STABILITY;
D O I
10.1016/j.ijpharm.2021.120571
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liposomes are spherical vesicles consisting of one or more concentric phospholipid bilayers enclosing an aqueous core. Being both nontoxic and biodegradable, liposomes represent a powerful delivery system for several drugs. They have improved the therapeutic efficacy of drugs through stabilizing compounds, overcoming obstacles to cellular and tissue uptake and increasing drug biodistribution to target sites in vivo, while minimizing systemic toxicity. This review offers an overview of liposomes, thought the exploration of their key fundamentals. Initially, the main design aspects to obtain a successful liposomal formulation were addressed, following the techniques for liposome production and drug loading. Before application, liposomes required an extensive characterization to assurance in vitro and in vivo performance. Thus, several properties to characterize liposomes were explored, such as size, polydispersity index, zeta potential, shape, lamellarity, phase behavior, encapsulation efficiency, and in vitro drug release. Topics related with liposomal functionalization and effective targeting strategies were also addressed, as well as stability and some limitations of liposomes. Finally, this review intends to explore the current market liposomes used as a drug delivery system in different therapeutic applications.
引用
收藏
页数:15
相关论文
共 144 条
[1]   Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]   The next generation of liposome delivery systems: Recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients [J].
Abra, RM ;
Bankert, RB ;
Chen, F ;
Egilmez, NK ;
Huang, K ;
Saville, R ;
Slater, JL ;
Sugano, M ;
Yokota, SJ .
JOURNAL OF LIPOSOME RESEARCH, 2002, 12 (1-2) :1-3
[3]   Liposome: classification, preparation, and applications [J].
Akbarzadeh, Abolfazl ;
Rezaei-Sadabady, Rogaie ;
Davaran, Soodabeh ;
Joo, Sang Woo ;
Zarghami, Nosratollah ;
Hanifehpour, Younes ;
Samiei, Mohammad ;
Kouhi, Mohammad ;
Nejati-Koshki, Kazem .
NANOSCALE RESEARCH LETTERS, 2013, 8
[4]   Construction of nanoscale multicompartment liposomes for combinatory drug delivery [J].
Al-Jamal, Wafa' T. ;
Kostarelos, Kostas .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 331 (02) :182-185
[5]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[6]   LIPOSOMES CONTAINING SYNTHETIC LIPID DERIVATIVES OF POLY(ETHYLENE GLYCOL) SHOW PROLONGED CIRCULATION HALF-LIVES INVIVO [J].
ALLEN, TM ;
HANSEN, C ;
MARTIN, F ;
REDEMANN, C ;
YAUYOUNG, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1066 (01) :29-36
[7]  
[Anonymous], 2014, APPL NANOTECHNOLOGY
[8]   CHANGE IN INTRAVESICULAR VOLUME OF LIPOSOMES BY FREEZE-THAW TREATMENT AS STUDIED BY THE ESR STOPPED-FLOW TECHNIQUE [J].
ANZAI, K ;
YOSHIDA, M ;
KIRINO, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1021 (01) :21-26
[9]   DSC for evaluating the encapsulation efficiency of lidocaine-loaded liposomes compared to the ultracentrifugation method [J].
Bakonyi, Monika ;
Szilvia, Berko ;
Maria, Budai-Szucs ;
Kovacs, Anita ;
Erzsebet, Csanyi .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2017, 130 (03) :1619-1625
[10]  
BANGHAM A.D., 1967, CHEM PHYS LIPIDS, VI, P225, DOI DOI 10.1016/0009-3084(67)90030-8